Epirubicin plus a calmodulin inhibitor (trifluoperazine) activity in advanced pancreatic adenocarcinoma. T.T.D. Cooperative Spanish Group.
Abad
A
A
Masuti
B
B
Camps
C
C
Font
A
A
Balañá
C
C
Vicent
J M
JM
Sánchez
J J
JJ
D000230:Adenocarcinoma / Q000188:drug therapy*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018432:Drug Resistance, Multiple; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000188:drug therapy*; D014268:Trifluoperazine / Q000008:administration & dosage
D014268:Trifluoperazine; D015251:Epirubicin